Corporate News 27-Jun-24
Jubilant Ingrevia's Bharuch unit successfully completes USFDA inspection
Jubilant Ingrevia announced successful outcome of the USFDA inspection with the receipt of Establishment Inspection report (EIR) with Zero 483 inspectional observations for the inspection performed in the month of April, 2024 at its manufacturing facility, Unit -1 located at Bharuch, Gujarat, India.
Previous News
Jubilant Ingrevia gets EIR for Bharuch facility from US FDA
( Hot Pursuit - 27-Jun-24 16:38 )
Jubilant Ingrevia consolidated net profit declines 29.08% in the December 2022 quarter
( Results - Announcements 31-Jan-23 14:45 )
Jubilant Ingrevia's Bharuch unit successfully completes USFDA inspection
( Corporate News - 27-Jun-24 18:00 )
Jubilant Ingrevia to declare Quarterly Result
( Corporate News - 09-May-23 16:49 )
Jubilant Ingrevia Q3 PAT slides 29% YoY to Rs 92 cr
( Hot Pursuit - 31-Jan-23 15:18 )
Jubilant Ingrevia raises Rs 75 cr via CP issue
( Corporate News - 20-Jul-22 09:27 )
Jubilant Ingrevia consolidated net profit declines 44.08% in the March 2024 quarter
( Results - Announcements 14-May-24 15:33 )
Board of Jubilant Ingrevia recommends Interim Dividend
( Corporate News - 02-Feb-22 09:43 )
Board of Jubilant Ingrevia recommends interim dividend
( Corporate News - 31-Jan-23 16:04 )
Jubilant Ingrevia to conduct board meeting
( Corporate News - 10-May-22 13:40 )
Jubilant Ingrevia plans to raise Rs 600 cr via CP issuance
( Corporate News - 18-Aug-23 14:08 )
Other Stories
E Factor Experiences AGM scheduled
03-Jul-24 13:55
Newjaisa Technologies EGM scheduled
03-Jul-24 13:55
Hindustan Zinc AGM scheduled
03-Jul-24 13:55
Mirza International schedules AGM
03-Jul-24 13:54
Sundaram Multi Pap to convene EGM
03-Jul-24 13:54
Kothari Petrochemicals to hold AGM
03-Jul-24 13:54
Kothari Sugars & Chemicals schedules AGM
03-Jul-24 13:54
Flair Writing Industries appoints CFO
03-Jul-24 11:09
Polycab India allots 12,495 equity shares under ESOS
03-Jul-24 10:21
Magenta Lifecare revises board meeting date
03-Jul-24 10:08
Back
Top
